Chile
Copper3D is a Chilean and US-based company that focuses on developing Antimicrobial Nanomaterials for the AM industry and the 3D Printing of Medical Applications, with full antimicrobial properties. The company prides itself on 'hacking' materials to make them clean and safe, thus disrupting the industry.
Established in 2017, Copper3D is committed to leveraging the power of innovation to reshape the future and save lives. As an FDA & EPA Registered Company, it is positioned to make a significant impact in the Biotechnology and Medical Devices industries.
With its focus on revolutionizing Antimicrobial 3D Printing, Copper3D offers a unique value proposition that aligns with the growing demand for advanced medical solutions.
However, specific details about last investment, investment amount, investors, location, and headquarters are unavailable at this time. As Copper3D continues to advance in the industry, it presents an intriguing opportunity for venture capitalists seeking to support innovative solutions with a potential for global impact.
For more information, please visit their website at www.copper3D.com or follow them on Instagram (copper3d_global), Twitter (@copper3d_global), and Facebook (www.facebook.com/Copper3D).
